First Patient Dosed in the US in Avacta’s AVA6000 Phase 1 Clinical Study
April 27, 2023Research and Development Avacta
Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, announces that the …
Novartis Cosentyx® gains positive CHMP opinion for hidradenitis suppurativa
April 27, 2023Business Services CHMP, Cosentyx, Dermatology, Novartis
Basel, April 26, 2023 — Novartis announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European …
GSK’s RSV vaccine candidate gains positive EMA CHMP opinion
April 27, 2023Medical Communications
GSK has announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has shared a …
FDA approves first orally-administered faecal microbiota product for preventing serious gut infection
April 27, 2023Medical Communications
The US Food and Drug Administration (FDA) has announced that it has approved the first orally-ingested faecal microbiota product for …
National Institutes of Health awards grant for gammaCore clinical trial for patients with opioid use disorders
April 27, 2023Research and Development
Bioelectronic medicine and wellness company electroCore have announced that the National Institute on Drug Abuse (NIDA) part of the National …
NICE recommends two CAR T treatments for blood cancers to the Cancer Drugs Fund
April 27, 2023Medical Communications
The National Institute for Health and Care Excellence (NICE) has announced that it is recommending two personalised immunotherapy treatments to …
Aldena Therapeutics and Empa Awarded InnoSuisse Funding to Advance STAR Particles as a Novel Drug Delivery Technology for Dermatology
April 26, 2023Business Services
Boston, Massachusetts, April 26, 2023 – Aldena Therapeutics Inc. (Aldena), a private biotech company pioneering siRNA-based therapies for dermatological indications, …
Epsilogen announces significant expansion of management team with three new senior hires
April 26, 2023Business Services
London, 26 April 2023 – Epsilogen Ltd, a global leader in the development of novel immunoglobulin E (IgE) antibodies to …
Real-world data analysis shows significant improvement in glycaemic management when using a blood glucose monitor connected to the mySugr® app in UK users with type 2 diabetes
April 26, 2023Business Services
Burgess Hill, 26 April 2023 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that real world data shows a …
FDA shares safety warning on amniotic fluid eyedrops
April 26, 2023Medical Communications
The US Food and Drug Administration (FDA) has released a Public Safety Notification on eyedrops containing amniotic fluid currently being …
FDA grants accelerated approval for QALSODY (tofersen) as ALS treatment
April 26, 2023Medical Communications
Biogen has announced that the US Food and Drug Administration (FDA) has approved QALSODY (tofersen) 100mg/15ml injection for the treatment …
UCB and Huma Therapeutics collaborate on digital health solution to improve rare disease management
April 26, 2023Medical Communications
Digital health company Huma Therapeutics and biopharmaceutical company UCB are partnering to offer a digital technology solution to aid patients …
Abbott announces two FDA clearances for life support system
April 26, 2023Medical Communications
US-based medical devices and healthcare company Abbott has announced two new clearances from the US Food and Drug Administration (FDA) …
MiNA Therapeutics Enters Research Collaboration with BioMarin Pharmaceutical to Advance RNAa Platform Research in Rare Genetic Diseases
April 25, 2023Business Services
London, United Kingdom, April 25, 2023 — MiNA Therapeutics, the pioneer of small activating RNA (RNAa) therapeutics, today announced a multi-target …
PureTech Founded Entity Vedanta Biosciences Announces $106.5 Million Financing to Advance Pipeline of Defined Bacterial Consortia Therapies
April 25, 2023Business Services
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company, noted today that its Founded …
Brain scanning technology to be used for clinical psychedelics trials in pioneering London start-up partnership
April 25, 2023Business Services
London, UK: Commercial trials for psychedelics-assisted medical treatments will now have access to state-of-the-art brain scanning technology thanks to a …
Alchemab Therapeutics to present data profiling a novel antibody to Huntingtin Exon 1 at the CHDI Annual Huntington’s Disease Therapeutics Conference
April 25, 2023Business Services
Cambridge, UK, April 25, 2023 – Alchemab Therapeutics, an antibody discovery company identifying naturally occurring antibodies from individuals resilient to …
EMA validates marketing authorisation application for Jemperli with chemotherapy
April 25, 2023Medical Communications
GSK has announced that the European Medicines Agency (EMA) has validated the company’s Type II Variation for a new indication …
3B Pharmaceuticals and Novartis enter into licensing agreement for FAP-targeting technology
April 25, 2023Research and Development
German biotechnology company 3B Pharmaceuticals (3BP) and Switzerland-based Novartis have announced that they have entered into a Global Exclusive Licensing …
NICE publishes Final Appraisal Document for multiple myeloma drug
April 25, 2023Medical Communications
The National Institute for Health and Care Excellence (NICE) has submitted a Final Appraisal Document (FAD) for the use of …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
